Patient preference to guide AFO prescriptio
Recruiting
- Conditions
- eurological disorders
- Registration Number
- NL-OMON28247
- Lead Sponsor
- Sint Maartenskliniek
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
Age >18 years old <80 years old
- Neurological disorders, such as stroke, MS, spinal cord injury
- At least 6 months post injury-onset to ensure a stable neurological condition
- Reduced ankle push-off power (clinically assessed by functional testing)
Exclusion Criteria
- Using orthopedic shoes in combination with AFO
- Receiving focal treatment for spasticity (e.g.with botulinum toxin) within 6 months
- Calf muscle hypertonia (Modified Ashworth scale (MAS) >2/5)
- Hip flexor and extensor weakness (MRC<4/5)
- Knee extensor weakness (MRC<4/5)
- Patient with neuropathic and/or orthopedic comorbidities that affect AFO efficacy
- Patient with cognitive impairment(s) not being able to follow instructions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method % agreement between patient’s preference and AFO efficacy in terms of L-test performance
- Secondary Outcome Measures
Name Time Method - % agreement between patient’s preference at baseline and at evaluation<br>- Relation between L-test performance and joint kinematics and kinetics<br>- % agreement between patient’s preference and AFO efficacy in terms of walking speed and gait adaptability<br> - % agreement between orthotist’s preference and AFO efficacy in terms of L-test performance, walking speed and gait adaptability <br>- Spatiotemporal parameters <br>- Joint kinematics and kinetics <br>- Shank-to-vertical angle (SVA) <br>- AFO stiffness <br>- AFO satisfaction score <br>- AFO adherence